Literature DB >> 27039787

Investigating Preoperative Hematologic Markers for Prediction of Ovarian Cancer Surgical Outcome.

Tahereh Ashrafganjoei1, Mahdiss Mohamadianamiri, Farah Farzaneh, Maryam Sadat Hosseini, Maliheh Arab.   

Abstract

PURPOSE: The current study aimed at assessing the association between neutrophil-lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) for the prognosis of the surgical outcome of epithelial ovarian cancer (EOC).
MATERIALS AND METHODS: EOC patient medical records of surgical operations between January, 2005 and December, 2015 were reviewed and their data of clinicopathological complete blood counts (CBCs) and surgical outcomes were collected. To assess their effects on surgical outcomes, PLR and NLR optimal predictive values were determined and then compared with each other.
RESULTS: A statistically significant relation was found between surgical outcomes and NLR and PLR (p<0.001 and p<0.001), for which new cutoff points were gained (PLR: 192,3,293; NLR: 3). The sensitivity and specificity were 0.74 and 0.67, respectively for PLR and 0.74 and 0.58, for NLR.
CONCLUSIONS: NLR and PLR seem to be useful methods for the prediction of surgical outcomes in patients with EOCs. Increased NLR and PLR proved to be beneficial for poor surgical outcomes. Moreover, PLR increase showed further help in the predicting outcome of EOC suboptimal debulking.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27039787     DOI: 10.7314/apjcp.2016.17.3.1445

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

Review 1.  The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer.

Authors:  Anastasia Prodromidou; Panagiotis Andreakos; Charalampos Kazakos; Dimitrios Eftimios Vlachos; Despina Perrea; Vasilios Pergialiotis
Journal:  Inflamm Res       Date:  2017-03-04       Impact factor: 4.575

2.  Platelet to white blood cell ratio predicts 30-day postoperative infectious complications in patients undergoing radical nephrectomy for renal malignancy.

Authors:  Alaina Garbens; Christopher J D Wallis; Georg Bjarnason; Girish S Kulkarni; Avery B Nathens; Robert K Nam; Raj Satkunasivam
Journal:  Can Urol Assoc J       Date:  2017-11       Impact factor: 1.862

3.  Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer.

Authors:  Yun-Ji Kim; Inha Lee; Young Shin Chung; EunJi Nam; Sunghoon Kim; Sang-Wun Kim; Young Tae Kim; Jung-Yun Lee
Journal:  Obstet Gynecol Sci       Date:  2018-02-05

4.  Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis.

Authors:  Yu Zhou; Dezhi Li; Ye Lin; Min Yu; Xin Lu; Zhixiang Jian; Ning Na; Baohua Hou
Journal:  Onco Targets Ther       Date:  2018-05-01       Impact factor: 4.147

5.  Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer

Authors:  Maliheh Arab; Farzaneh Jamdar; Maryam Sadat Hosseini; Robabe Ghodssi- Ghasemabadi; Farah Farzaneh; Tahereh Ashrafganjoei
Journal:  Asian Pac J Cancer Prev       Date:  2018-05-26

6.  The role of inflammation biomarkers in differential diagnosis of pelvic tumours of ovarian origin: a single-centre observational study.

Authors:  Victoria Psomiadou; Anastasia Prodromidou; Elpis Galati; Ioannis D Kostakis; Athanasios Maliaros; Ioannis Mamais; Nikolaos Blontzos; Fotios Lefkopoulos; Christos Iavazzo; George Vorgias
Journal:  Contemp Oncol (Pozn)       Date:  2021-04-15

7.  Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors.

Authors:  Tae Hui Yun; Yoon Young Jeong; Sun Jae Lee; Youn Seok Choi; Jung Min Ryu
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.